Propranolol: Expert Cardiovascular and Neurological Management
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.19 (0%) | 🛒 Add to cart |
| 20 | $2.26 | $80.39 $45.22 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.58 $50.24 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $241.17 $55.27 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $361.75 $60.29 (83%) | 🛒 Add to cart |
| 120 | $0.54 | $482.33 $65.32 (86%) | 🛒 Add to cart |
| 180 | $0.45 | $723.50 $80.39 (89%) | 🛒 Add to cart |
| 270 | $0.37 | $1085.25 $100.49 (91%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $1446.99 $120.58 (92%) | 🛒 Add to cart |
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.52 | $45.22 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $90.44 $50.24 (44%) | 🛒 Add to cart |
| 30 | $1.84 | $135.66 $55.27 (59%) | 🛒 Add to cart |
| 60 | $1.00 | $271.31 $60.29 (78%) | 🛒 Add to cart |
| 90 | $0.73 | $406.97 $65.32 (84%) | 🛒 Add to cart |
| 120 | $0.67 | $542.62 $80.39 (85%) | 🛒 Add to cart |
| 180 | $0.56 | $813.93 $100.49 (88%) | 🛒 Add to cart |
| 270 | $0.47 | $1220.90 $125.61 (90%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $1627.87 $155.75 (90%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Propranolol is a non-selective beta-adrenergic blocking agent, representing a cornerstone in the therapeutic management of a spectrum of cardiovascular and neurological conditions. As a first-generation beta-blocker, its mechanism of action involves competitive antagonism of catecholamines at both β₁- and β₂-adrenergic receptor sites. This foundational activity underpins its efficacy in modulating heart rate, myocardial contractility, and conduction velocity, while its lipophilic nature allows for penetration of the blood-brain barrier, facilitating its utility in central nervous system-related indications. Its well-established pharmacokinetic and pharmacodynamic profile, supported by decades of rigorous clinical use and evidence, positions it as a versatile and reliable agent for specialists in cardiology, neurology, and internal medicine.
Features
- Pharmacological Class: Non-selective beta-adrenergic receptor antagonist (beta-blocker).
- Mechanism of Action: Competitively blocks catecholamine effects at β₁- and β₂-adrenergic receptors.
- Bioavailability: Approximately 25% due to significant first-pass metabolism.
- Half-life: Elimination half-life is roughly 3 to 6 hours.
- Protein Binding: Heavily protein-bound (90%).
- Metabolism: Extensive hepatic metabolism via the CYP2D6 enzyme pathway.
- Excretion: Primarily renal excretion of metabolites.
- Formulations: Available in immediate-release (IR) tablets and long-acting sustained-release (SR) capsules.
Benefits
- Provides precise control of ventricular rate in patients with atrial fibrillation and flutter.
- Reduces myocardial oxygen demand, offering protective anti-ischemic and anti-anginal effects.
- Effectively manages the somatic symptoms of performance anxiety and essential tremor.
- Serves as a foundational prophylactic therapy for migraine headache prevention.
- Can lower portal vein pressure in selected patients with cirrhosis, reducing the risk of variceal bleeding.
- Offers a well-tolerated option for the management of hypertension with a long-standing safety record.
Common use
Propranolol is indicated for the management of a diverse array of medical conditions. Its primary cardiovascular applications include the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is a mainstay in the management of angina pectoris, where it reduces the frequency of anginal episodes and increases exercise tolerance. It is also critical for rate control in tachyarrhythmias, such as supraventricular tachycardia, atrial fibrillation, and atrial flutter. In neurology, it is a first-line agent for the prophylaxis of migraine headaches and is highly effective in managing essential tremor. Furthermore, it is utilized off-label for the symptomatic relief of situational anxiety (e.g., performance anxiety) and as part of the management strategy for thyrotoxicosis and prophylaxis of variceal hemorrhage in portal hypertension.
Dosage and direction
Dosage is highly individualized based on the specific indication, patient response, and tolerability. Therapy should be initiated at a low dose and titrated upward gradually.
- Hypertension: Initial dose is often 40 mg IR twice daily, with maintenance doses ranging from 120 to 240 mg per day administered in divided doses. The SR formulation allows for once-daily dosing (e.g., 80 mg to 160 mg daily).
- Angina Pectoris: Starting doses of 80 mg IR per day in divided doses are common, with a typical maintenance range of 160 to 240 mg per day.
- Arrhythmias: 10 mg to 30 mg IR three or four times daily, before meals and at bedtime.
- Migraine Prophylaxis: The initial dose is typically 80 mg per day (IR in divided doses or SR) with a usual effective dose range of 160-240 mg per day.
- Essential Tremor: Starting at 40 mg IR twice daily, with effective doses often between 120 mg and 320 mg daily in divided doses.
- Administration: Immediate-release tablets can be taken with or without food, but consistency is key for predictable absorption. Sustained-release capsules must be swallowed whole and not crushed, chewed, or divided. Abrupt discontinuation of propranolol should be avoided; therapy should be withdrawn gradually over a period of 1-2 weeks under medical supervision to avoid a rebound hypertensive or ischemic phenomenon.
Precautions
Close monitoring is required for patients prescribed propranolol. It can mask the tachycardic signs of hypoglycemia in diabetic patients, making them less aware of an impending insulin reaction. It can also blunt the normal cardiovascular response to hemodynamic stress and can exacerbate heart failure in susceptible individuals. Caution is advised in patients with compensated heart failure, as it can be used but requires very careful titration and monitoring. Bronchospasm can occur in patients with reactive airway disease (asthma, COPD) due to β₂-receptor blockade. It may reduce intraocular pressure, potentially interfering with glaucoma screening. Patients should be advised that propranolol can cause fatigue, dizziness, and cold extremities.
Contraindications
Propranolol is contraindicated in patients with:
- Cardiogenic shock.
- Sinus bradycardia and greater than first-degree heart block.
- Bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
- Overt cardiac failure (unless the failure is secondary to a tachyarrhythmia treatable with propranolol).
- Hypersensitivity to propranolol or any component of the formulation.
- Severe peripheral arterial circulatory disorders.
Possible side effect
Adverse reactions are generally dose-dependent and often related to its pharmacological beta-blockade.
- Common: Bradycardia, cold extremities, fatigue, dizziness, insomnia, vivid dreams or nightmares, nausea, diarrhea, constipation.
- Less Common: Depression, dyspnea or wheezing (especially in predisposed patients), heart failure, hypotension, masking of hypoglycemia symptoms, erectile dysfunction.
- Rare: Psoriasiform rash or exacerbation of psoriasis, agranulocytosis, non-thrombocytopenic purpura, thrombocytopenic purpura, mesenteric arterial thrombosis.
Drug interaction
Propranolol has a significant potential for pharmacokinetic and pharmacodynamic interactions.
- CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Quinidine): Can increase propranolol plasma concentrations, potentiating its effects and side effects.
- Other Antihypertensives (e.g., Calcium Channel Blockers like Verapamil/Diltiazem, Alpha-blockers): Can lead to additive hypotensive effects and/or bradycardia. Concomitant use with verapamil can cause severe hypotension and heart block.
- Insulin and Oral Hypoglycemics: Increased risk of hypoglycemia; masks warning signs like tachycardia.
- Sympathomimetics (e.g., Epinephrine, Albuterol): Propranolol can antagonize the effects of beta-agonists and may lead to unopposed alpha-adrenergic activity (e.g., severe hypertension from epinephrine).
- NSAIDs (e.g., Ibuprofen, Naproxen): May antagonize the antihypertensive effect of propranolol.
- Warfarin: May increase warfarin concentration and prolong prothrombin time.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patients should never take a double dose to make up for a missed one. Maintaining a consistent dosing schedule is crucial for stable therapeutic effect.
Overdose
Overdose with propranolol is a medical emergency characterized primarily by profound bradycardia, hypotension, congestive heart failure, bronchospasm, and hypoglycemia. Cardogenic shock and seizures may also occur. Symptoms can progress rapidly. Management is supportive and includes:
- Cardiovascular Support: Administering IV fluids and vasopressors (e.g., norepinephrine, epinephrine) for hypotension and shock. Atropine can be used for bradycardia. In refractory cases, a cardiac pacemaker may be required. Glucagon is a first-line antidote due to its positive inotropic and chronotropic effects that are not mediated by beta-receptors.
- Respiratory Support: Bronchodilators (e.g., beta-agonists like isoproterenol, theophylline) for bronchospasm.
- Metabolic Correction: IV glucose for hypoglycemia.
- Gastric lavage may be considered if presentation is very early after ingestion.
Storage
Propranolol should be stored at controlled room temperature, 20°C to 25°C (68°F to 77°F), in a tightly closed container. It must be protected from light, moisture, and excessive heat. All medications should be kept out of reach of children and pets. Unused or expired medication should be disposed of properly via a take-back program or according to FDA guidelines, not flushed down the toilet.
Disclaimer
This information is intended for educational and informational purposes only for healthcare professionals and does not constitute medical advice. It is not a substitute for the professional judgment of a qualified healthcare provider in diagnosing and treating patients. The content provided is based on general pharmacological principles and may not encompass all possible uses, directions, precautions, interactions, or adverse effects. Dosage and treatment decisions must be made by a licensed medical professional based on an individual patient’s clinical status and official prescribing information. Always refer to the full manufacturer’s prescribing information before initiating any therapy.
Reviews
- “As a consulting cardiologist, propranolol remains an indispensable tool in my arsenal for rate control in AFib, particularly in patients without reactive airway disease. Its predictable pharmacokinetics allow for fine-tuning.” – Dr. E. Lawson, MD, FACC
- “For essential tremor, the efficacy of propranolol is often remarkable. It provides patients with a significant improvement in quality of life and functional capacity. The key is a slow titration to find the minimal effective dose.” – Neurologist, Academic Medical Center
- “We utilize propranolol extensively in our headache clinic for migraine prophylaxis. A significant proportion of our patients achieve a >50% reduction in migraine frequency and severity with tolerable side effects.” – Headache Specialist, RN
- “The sustained-release formulation has improved adherence in my hypertensive patients, allowing for once-daily dosing while maintaining consistent 24-hour coverage. A classic drug that continues to prove its worth.” – Internal Medicine Physician